Filomena Napolitano | Immunology and Microbiology | Innovative Research Award

Innovative Research Award

Filomena Napolitano — University of Naples Federico II

Filomena Napolitano
Affiliation University of Naples Federico II
Country Italy
Scopus ID 57201650666
Documents 30
Citations 395
h-index 13
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0003-1925-9912

Filomena Napolitano is a researcher affiliated with the University of Naples Federico II, Italy, whose stated subject area is Immunology and Microbiology. The supplied Scopus profile reports 30 documents, 395 citations, and an h-index of 13, providing quantitative indicators of the scholarly record associated with the identified author profile. [1]

This academic recognition page presents the available research information in relation to the Innovative Research Award under the World Science Awards. The profile combines bibliographic indicators with a qualitative discussion of research contribution, publication activity, and potential award relevance while avoiding conclusions that cannot be established from the supplied data alone. [3]

Abstract

Filomena Napolitano is a researcher associated with the University of Naples Federico II in Italy and identified within the broad subject area of Immunology and Microbiology. The supplied bibliometric information records 30 documents, 395 citations, and an h-index of 13. [1] These indicators provide a quantitative description of the scholarly record represented by the identified Scopus author profile. The researcher is considered in connection with the Innovative Research Award of the World Science Awards, with the available evidence supporting an assessment of research activity and scholarly visibility while recognizing that bibliometric measures alone do not establish research quality or innovation.

Keywords

  • Innovative Research Award
  • Filomena Napolitano
  • Immunology
  • Microbiology
  • Immunology and Microbiology Research
  • Pharmaceutical and Biomedical Research
  • Research Impact
  • University of Naples Federico II
  • World Science Awards

Introduction

Immunology and Microbiology encompass interconnected areas of biomedical science concerned with immune responses, infectious organisms, host–microbe interactions, disease mechanisms, diagnostics, therapeutics, and related biological processes. Research across these fields contributes to understanding health and disease and can support the development of new scientific approaches in medicine and biotechnology.

Within this academic context, Filomena Napolitano is identified with the University of Naples Federico II in Italy. The supplied Scopus record reports 30 documents, 395 citations, and an h-index of 13. [1] These values provide a snapshot of publication and citation activity associated with the identified author profile, while the researcher’s ORCID identifier, 0000-0003-1925-9912, provides a persistent identifier for scholarly attribution. [2]

Research Profile

The available profile information places Filomena Napolitano within Immunology and Microbiology and identifies the University of Naples Federico II as the institutional affiliation. The supplied Scopus author identifier is 57201650666. [1] The ORCID identifier is 0000-0003-1925-9912, which can assist in distinguishing the researcher’s scholarly output from that of other authors with similar names. [2]

Bibliometric indicators should be interpreted alongside the disciplinary context, publication chronology, authorship structure, journal characteristics, and research objectives represented in individual studies. Accordingly, the reported metrics provide useful descriptive information but should not be considered a comprehensive assessment of scientific originality, methodological rigor, or practical significance.

Research Contributions

The supplied information identifies Immunology and Microbiology as the principal subject area associated with Filomena Napolitano. Research in this domain can address fundamental and applied questions involving immune regulation, microorganisms, host–pathogen relationships, cellular responses, molecular mechanisms, disease processes, and the development of diagnostic or therapeutic strategies. The specific contributions of an individual researcher should be established through publication-level evidence rather than inferred solely from aggregate bibliometric measures.

  • A documented scholarly record comprising 30 reported documents.
  • A reported citation count of 395 associated with the supplied Scopus profile.
  • An h-index of 13 in the supplied bibliometric record.
  • Research affiliation with the University of Naples Federico II.
  • Academic positioning within Immunology and Microbiology.
  • A persistent ORCID identifier supporting researcher identity and publication attribution.

A fuller evaluation of research contribution would consider the originality of the research questions, methodological quality, reproducibility, interdisciplinary collaboration, contribution to knowledge, and evidence of application or influence within the relevant scientific community.

Publications

The supplied Scopus information reports 30 documents associated with Filomena Napolitano’s author profile. [1] The provided input does not include individual publication titles, journal details, publication dates, article types, or verified DOI identifiers. Consequently, specific publications and DOI records are not attributed here without direct publication-level verification.

The complete publication record may be examined through the researcher’s Scopus author profile and ORCID record. Scopus provides bibliographic and citation information, while ORCID provides persistent researcher identification and can connect scholarly works with the appropriate researcher record. [1] [2]

No publication-specific DOI has been supplied in the source information for this article. Where individual publications are subsequently verified, their DOI records can be incorporated using persistent DOI links such as https://doi.org/.

Research Impact

The supplied bibliometric record contains 395 citations across 30 documents. Based on these reported values, the citation-to-document ratio is approximately 13.2 citations per document. The profile also reports an h-index of 13, indicating that the indexed record contains at least 13 publications that have each received at least 13 citations under the relevant counting conditions. [1]

Citation measures can provide evidence of scholarly visibility, but citation practices differ across fields, publication types, research communities, and publication periods. For this reason, citation count and h-index should be interpreted together with the substance of the research, the significance of individual findings, methodological quality, collaboration, and evidence of influence beyond citation activity.

Award Suitability

The Innovative Research Award associated with the World Science Awards provides a context for recognizing research activity and scientific contributions. [3] Based on the supplied information, Filomena Napolitano has a documented research profile in Immunology and Microbiology, an affiliation with the University of Naples Federico II, 30 reported documents, 395 citations, and an h-index of 13. [1]

These indicators provide relevant quantitative evidence for an academic recognition profile. The ORCID record further provides a persistent scholarly identifier for the researcher. [2] Nevertheless, final award suitability should be determined using the official award criteria together with verified publication records, research originality, scientific contribution, methodological strength, academic development, and supporting evidence.

  1. Review the verified publication record and research outputs associated with the researcher.
  2. Assess originality, scientific relevance, methodological quality, and contribution to Immunology and Microbiology.
  3. Consider citation and other bibliometric indicators as supporting evidence rather than as the sole basis for evaluation.
  4. Apply the official World Science Awards evaluation criteria to determine final award eligibility and recognition.

Conclusion

Filomena Napolitano is a researcher affiliated with the University of Naples Federico II in Italy and associated with the field of Immunology and Microbiology. The supplied Scopus profile reports 30 documents, 395 citations, and an h-index of 13, while the ORCID identifier 0000-0003-1925-9912 provides a persistent identifier for the researcher’s scholarly identity. [1] [2]

The available information establishes a substantive bibliometric profile that may be considered in connection with the Innovative Research Award. A complete recognition decision should nevertheless incorporate verified research outputs and qualitative evidence of innovation, originality, scientific contribution, and research significance, alongside the official criteria of the World Science Awards. [3]

References

    1. Elsevier. (n.d.). Scopus author details: Filomena Napolitano, Author ID 57201650666. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57201650666

Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

Dr. Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

clinical research assistant at Ankara Yildirim Beyazit University, Turkey

Nazila Bahmaie is a dedicated researcher and PhD candidate specializing in Cancer Biology. Born in Ahvaz, Iran, on December 21, 1990, she has pursued an academic and research career across multiple countries, including Iran, Cyprus, and Turkey. Currently enrolled at Ankara Yildirim Beyazit University in Turkey, Nazila is focused on advancing her expertise in cancer biology. Her international academic experience has allowed her to engage with diverse research methodologies, enhancing her scientific adaptability. With a deep commitment to biomedical research, she aims to contribute to groundbreaking discoveries in cancer treatment and immunology. Nazila’s extensive background in medical sciences reflects her passion for understanding complex biological processes and her dedication to improving global healthcare outcomes.

Professional Profile

Education

Nazila Bahmaie has an impressive academic background, with degrees in cellular and molecular biology, medical microbiology, and immunology. She completed her BSc in Cellular and Molecular Biology, majoring in Microbiology, at Maragheh University in Iran, followed by an MSc in Medical Microbiology and Immunology at Zanjan University of Medical Sciences, where she graduated with distinction. Continuing her academic journey, she pursued a PhD in Immunology and Allergy at Near East University in Cyprus before transferring to her current PhD program in Cancer Biology at Ankara Yildirim Beyazit University in Turkey. Her educational trajectory demonstrates a consistent focus on biology and medical sciences, with an emphasis on translational research that bridges basic science and clinical applications.

Professional Experience

Nazila Bahmaie’s professional journey includes significant research roles in cancer biology, immunology, and medical microbiology. As a PhD candidate at Ankara Yildirim Beyazit University, she conducts cancer research under the guidance of prominent scientists, focusing on cancer biology and immunological mechanisms. Before this, she contributed to the field of immunology during her PhD fellowship at Near East University, where she explored pediatric immunology and allergy. Nazila has also worked in medical microbiology, conducting essential research during her MSc studies at Zanjan University of Medical Sciences. Her professional experiences have equipped her with diverse research skills, including cellular and molecular techniques, and a deep understanding of immune responses in diseases.

Research Interests

Nazila Bahmaie’s research interests are focused on the intersection of cancer biology and immunology, particularly in understanding the molecular mechanisms that drive cancer progression and how the immune system can be leveraged to treat cancers. She is deeply involved in studying the immune responses in cancer patients and exploring innovative immunotherapy approaches that could lead to more effective treatments. Her background in microbiology also informs her interest in how microbial infections can influence immune regulation and cancer development. Nazila aims to contribute to the development of targeted therapies that enhance the body’s immune response against tumors, making her research both translational and clinically relevant.

Awards and Honors

Nazila Bahmaie has consistently excelled throughout her academic career, earning high honors and recognition for her academic performance. She graduated with distinction during her MSc in Medical Microbiology and Immunology, earning an A++ for her academic achievements at Zanjan University of Medical Sciences. In addition, she successfully secured a PhD fellowship in Immunology and Allergy at Near East University, showcasing her dedication and merit in the field. While specific awards and honors related to her current PhD work are not detailed, her academic trajectory and continuous involvement in research highlight her potential for future recognition in the scientific community, particularly in cancer biology and immunology.

Conclusion

Nazila Bahmaie has a solid academic foundation and promising potential, particularly in the fields of cancer biology and immunology. However, to be a strong contender for the Best Researcher Award, she would benefit from expanding her publication portfolio, demonstrating a clear impact of her research, and engaging in leadership roles. If she addresses these areas, she could emerge as a notable candidate in future award cycles.

Publication top noted

  • 📄 47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study)
    • Authors: Daneshi, N., Esmaeilzadeh, A., Bahmaie, N.
    • Journal: Eurasian Journal of Medicine
    • Year: 2022
    • Citations: 1
  • 📄 Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Diseases
    • Authors: Daneshi, N., Bahmaie, N., Esmaeilzadeh, A.
    • Journal: Cell Journal
    • Year: 2022
    • Citations: 3
  • 📄 Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study
    • Authors: Esmaeilzadeh, A., Bahmaie, N., Nouri, E., Hajkazemi, M.J., Rafie, M.Z.
    • Journal: International Journal of Molecular Sciences
    • Year: 2021
    • Citations: 8
  • 📄 The Clinical Efficacy of Rituximab Administration in Autoimmunity Disorders, Primary Immunodeficiency Diseases and Malignancies
    • Authors: Zian, Z., Berry, S.P.D.-G., Bahmaie, N., Khan, H., Azizi, G.
    • Journal: International Immunopharmacology
    • Year: 2021
    • Citations: 5
  • 📄 Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders
    • Authors: Khosh, E., Bahmaie, N., Elahi, R., Esmaeilzadeh, A.
    • Journal: Iranian Journal of Allergy, Asthma and Immunology
    • Year: 2020
    • Citations: 2